Investment Thesis
Baxter is experiencing severe profitability deterioration with negative operating and net margins despite revenue growth, indicating fundamental operational challenges rather than cyclical weakness. The company is burning shareholder value with negative ROE (-15.6%) and ROA (-4.8%), while maintaining elevated debt levels (1.54x D/E) that limit financial flexibility to address underlying issues.
BAX Strengths
- Positive revenue growth of 5.7% YoY demonstrates continued market demand
- Healthy liquidity position with 2.31x current ratio and $2.0B cash providing operational flexibility
- Positive operating cash flow of $845M and free cash flow of $332M showing some cash generation despite net losses
BAX Risks
- Significant operating losses (-$308M) and net losses (-$957M) indicating core business profitability crisis
- Deteriorating earnings per share (-47.2% YoY decline) suggests accelerating value destruction
- High leverage (1.54x D/E, $9.4B long-term debt) with negative interest coverage (-1.1x) creates vulnerability if operational performance doesn't improve
- Negative returns on equity and assets signal poor capital allocation and operational inefficiency
Key Metrics to Watch
- Operating margin trend and path to profitability in next 2-3 quarters
- Gross margin sustainability and whether 30.1% can be maintained
- Debt reduction progress and interest coverage ratio recovery to positive territory
BAX Financial Metrics
BAX Profitability Ratios
BAX Balance Sheet & Liquidity
BAX 5-Year Financial Trend
5-Year Trend Summary: BAXTER INTERNATIONAL INC's revenue has declined by 12% over the 5-year period, indicating business contraction. The most recent EPS of $5.23 reflects profitable operations.
BAX Growth Metrics (YoY)
BAX Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2.7B | -$46.0M | $-0.09 |
| Q2 2025 | $2.7B | $91.0M | $0.18 |
| Q1 2025 | $2.5B | $37.0M | $0.07 |
| Q3 2024 | $2.6B | -$137.0M | $-0.27 |
| Q2 2024 | $3.7B | -$97.0M | $-0.19 |
| Q1 2024 | $3.5B | $37.0M | $0.07 |
| Q3 2023 | $3.6B | $2.4B | $4.76 |
| Q2 2023 | $3.6B | -$97.0M | $-0.19 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BAX Capital Allocation
BAX SEC Filings
Access official SEC EDGAR filings for BAXTER INTERNATIONAL INC (CIK: 0000010456)